LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) was the recipient of a significant decline in short interest during the month of October. As of October 31st, there was short interest totalling 21,800 shares, a decline of 25.3% from the October 15th total of 29,200 shares. Approximately 0.2% of the shares of the company are sold […]
LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) was the recipient of a large decrease in short interest in the month of September. As of September 15th, there was short interest totalling 37,900 shares, a decrease of 15.0% from the August 31st total of 44,600 shares. Currently, 0.3% of the shares of the company are short […]
LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) and Dr. Reddy’s Laboratories (NYSE:RDY – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk. Earnings & Valuation This table compares LAVA […]
LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totalling 37,900 shares, a decrease of 15.0% from the August 31st total of 44,600 shares. Based on an average daily volume of 34,700 shares, the short-interest ratio is […]
LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) and Dr. Reddy’s Laboratories (NYSE:RDY – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings. Analyst Ratings This is a breakdown of […]